Impact of adjuvant endocrine therapy utilization in male patients with early breast cancer: results from a large German real-world claims data analysis

Male breast cancer (BC) is a rare entity and represents a significant clinical challenge due to its late diagnosis and resulting poorer prognosis compared to female BC. As shown by prior studies, approximately 99% of male BC patients are hormone receptor-positive (HR +). This study aimed to evaluate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dannehl, Dominik (VerfasserIn) , Dijkstra, Tjeerd Maarten Hein (VerfasserIn) , Au, Alexandra von (VerfasserIn) , Scholz, Anna (VerfasserIn) , Volmer, Léa (VerfasserIn) , Hahn, Markus (VerfasserIn) , Hawighorst, Sabine (VerfasserIn) , Chaudhuri, Ariane (VerfasserIn) , Ţăran, Florin-Andrei (VerfasserIn) , Wallwiener, Markus (VerfasserIn) , Bauer, Armin (VerfasserIn) , Wallwiener, Diethelm (VerfasserIn) , Brucker, Sara (VerfasserIn) , Wallwiener, Stephanie (VerfasserIn) , Hartkopf, Andreas (VerfasserIn) , Engler, Tobias (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 October 2025
In: Archives of gynecology and obstetrics
Year: 2025, Jahrgang: 312, Heft: 6, Pages: 2123-2129
ISSN:1432-0711
DOI:10.1007/s00404-025-08198-x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00404-025-08198-x
Resolving-System, kostenfrei: https://doi.org/10.1007/s00404-025-08198-x
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00404-025-08198-x
Volltext
Verfasserangaben:Dominik Dannehl, Tjeerd Maarten Hein Dijkstra, Alexandra von Au, Anna Sophie Scholz, Léa Louise Volmer, Markus Hahn, Sabine Hawighorst-Knapstein, Ariane Chaudhuri, Florin-Andrei Taran, Markus Wallwiener, Armin Bauer, Diethelm Wallwiener, Sara Yvonne Brucker, Stephanie Wallwiener, Andreas Hartkopf, Tobias Engler
Beschreibung
Zusammenfassung:Male breast cancer (BC) is a rare entity and represents a significant clinical challenge due to its late diagnosis and resulting poorer prognosis compared to female BC. As shown by prior studies, approximately 99% of male BC patients are hormone receptor-positive (HR +). This study aimed to evaluate the utilization and impact of adjuvant endocrine therapy (ET) in male early BC patients using a large German real-world claims dataset.
Beschreibung:Online Resource
ISSN:1432-0711
DOI:10.1007/s00404-025-08198-x